A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey

British Journal of Cancer

Volumn 75, Issue 7, 1997, Pages 1075-1079

  Thomas, H V ^a   Key, T J ^a   Allen, D S ^b   Moore, J W ^b   Dowsett, M ^c   Fentiman, I S ^d   Wang, D Y ^e  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Oestradiol; Premenopausal breast cancer; Progesterone; Prospective study; Sex hormone binding globulin; Testosterone

Indexed keywords

ESTRADIOL; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; UNITED KINGDOM;

EID: 0031000928     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.183     Document Type: Article

References (18)

1. Bernstein L, Yuan JM, Ross RK, Pike MC, Hanisch R, Lobo R, Stanczyk F, Gao Y-T and Henderson BE (1990) Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control 1: 51-58
2. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S and Secreto G (1996) Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88: 291-296
3. Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA and Schatzkin A (1996) Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 533-539
4. Hammond GL, Langley MS and Robinson PA (1985) A liquid-phase immunoradiometric assay for human sex-hormone-binding-globulin. J Steroid Biochem 23: 451-460
5. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB and Comstock GW (1994) A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 18: 79-85
6. Key TJA and Pike MC (1988) The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-43
7. Key TJA, Pike MC, Moore JW, Bulbrook RD, Clark GMG, Allen DS and Wang DY (1989) The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapy. Contraception 39: 179-186
8. Key TJA, Wang DY, Brown JB, Hermon C, Allen DS, Moore JW, Bulbrook RD, Fentiman IS and Pike MC (1996) A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer 73: 1615-1619
9. Malarkey WB, Schroeder LL, Stevens VC, James AG and Lanese RR (1977) Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 37: 4655-4659
10. Moore JW, Clark GMG, Hoare SA, Millis RR, Hayward JL, Quinlan MK. Wang DY and Bulbrook RD (1986) Binding of oestradiol to blood proteins and aetiology of breast cancer, Int J Cancer 38: 625-630
11. Moore JW, Key TJA, Bulbrook RD, Clark GMG, Allen DS, Wang DY and Pike MC (1987) Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Cancer 56: 661-666
12. Pike MC, Spicer DV, Dahmoush L and Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17-35
13. Rosenberg CR, Pasternack BS, Shore RE, Koenig KL and Toniolo PG (1994) Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 140: 518-525
14. Secreto G, Recchione C, Fariselli G and Di Pietro S (1984) High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast. Cancer Res 44: 841-844
15. Secreto G, Toniolo P, Pisani P, Recchione C, Cavalleri A, Fariselli G, Totis A, Di Pietro S and Berrino F (1989) Androgens and breast cancer in premenopausal women. Cancer Res 49: 471-476
16. Siiteri PK, Hammond GL and Nisker JA (1981) Increased availability of serum estrogens in breast cancer: a new hypothesis. In Hormones and Breast Cancer. Pike MC, Siiteri PK and Welsch CW (eds), pp. 87-106. Cold Spring Harbor Laboratory Press: New York
17. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P and Pasternack BS (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87: 190-197
18. Wysowski DK, Comstock GW, Helsing KJ and Lau HL (1987) Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 125: 791-799